Revenue From Anticancer Drug Market Is Expected To Reach $156 Billion By 2025

Healthcare

The global anticancer drugs market is set to enjoy a valuation of US$ 172.8 Billion in 2022 and further expand at a CAGR of 6.8% to reach US$ 335 Billion by the end of 2032.

Anticancer drugs account for more than half of global spending on cancer treatment. With more emphasis on drugs, the share of anticancer drugs treatment is likely to increase in collective spending on cancer treatment.

Request Sample

Competitive Landscape

Prominent anticancer drugs manufacturers are Hoffmann-La Roche Ltd, AbbVie, Eli Lilly and Company, Novartis AG, Pfizer Inc., Bayer AG, AstraZeneca, Takeda Pharmaceutical Company Limited, Merck & Co., Inc., Celgene Corporation, Amgen Inc.

The two main strategies used by the major players in the anti-cancer medicine business are the introduction of new products and acquisitions. A significant amount of market enthusiasm is being fueled by player collaboration on research and development as well as the FDA’s fast track approval for life-saving conditions.

  • In Dec 2020, To find and create innovative treatments using E3 degraders against difficult-to-drug targets, AbbVie and Frontier Medicines, Crop. have formed a cooperation.
  • In Jan 2021, Bayer expanded its pipeline of prostate cancer treatments by entering into a pharmaceutical purchase agreement with Noria Therapeutics and PSMA Therapeutics.

Fact.MR has provided detailed information about the price points of key manufacturers of Anticancer drugs positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.

Segmentation of Anticancer Drugs Industry Research

  • By Drug Class:

    • Cytotoxic
    • Hormonal Therapy
    • Targeted Therapy
      • Monoclonal antibodies
      • Small molecule inhibitors
  • By Cancer Type:

    • Prostate Cancer
    • Lung Cancer
    • Breast Cancer
    • Melanoma
    • Colon and Rectum Cancer
    • Others
  • By Distribution Channel:

    • Hospital Pharmacies
    • Retail Pharmacies
  • By Region:

    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia & ASEAN
    • Oceania
    • MEA

Leave a Reply

Related Posts